Article ; Online: Advancing nanotechnology for neoantigen-based cancer theranostics.
2024 Volume 53, Issue 7, Page(s) 3224–3252
Abstract: Neoantigens play a pivotal role in the field of tumour therapy, encompassing the stimulation of anti-tumour immune response and the enhancement of tumour targeting capability. Nonetheless, numerous factors directly influence the effectiveness of ... ...
Abstract | Neoantigens play a pivotal role in the field of tumour therapy, encompassing the stimulation of anti-tumour immune response and the enhancement of tumour targeting capability. Nonetheless, numerous factors directly influence the effectiveness of neoantigens in bolstering anti-tumour immune responses, including neoantigen quantity and specificity, uptake rates by antigen-presenting cells (APCs), residence duration within the tumour microenvironment (TME), and their ability to facilitate the maturation of APCs for immune response activation. Nanotechnology assumes a significant role in several aspects, including facilitating neoantigen release, promoting neoantigen delivery to antigen-presenting cells, augmenting neoantigen uptake by dendritic cells, shielding neoantigens from protease degradation, and optimizing interactions between neoantigens and the immune system. Consequently, the development of nanotechnology synergistically enhances the efficacy of neoantigens in cancer theranostics. In this review, we provide an overview of neoantigen sources, the mechanisms of neoantigen-induced immune responses, and the evolution of precision neoantigen-based nanomedicine. This encompasses various therapeutic modalities, such as neoantigen-based immunotherapy, phototherapy, radiotherapy, chemotherapy, chemodynamic therapy, and other strategies tailored to augment precision in cancer therapeutics. We also discuss the current challenges and prospects in the application of neoantigen-based precision nanomedicine, aiming to expedite its clinical translation. |
---|---|
MeSH term(s) | Humans ; Antigens, Neoplasm ; Precision Medicine ; Neoplasms/diagnosis ; Neoplasms/therapy ; Immunotherapy ; Nanotechnology ; Cancer Vaccines ; Tumor Microenvironment |
Chemical Substances | Antigens, Neoplasm ; Cancer Vaccines |
Language | English |
Publishing date | 2024-04-02 |
Publishing country | England |
Document type | Journal Article ; Review |
ZDB-ID | 1472875-8 |
ISSN | 1460-4744 ; 0306-0012 |
ISSN (online) | 1460-4744 |
ISSN | 0306-0012 |
DOI | 10.1039/d3cs00162h |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.